Products

Primary tabs

Export products to Excel

Displaying 91 - 105 of 213
Product Alternative Name Development Status Target Mode Active Pharmaceutical Ingredient (API) Delivery Type Duration Type Project Stage Partner Updated date
Kyleena LNG Contraceptive IUS (LCS), LCS16 SRA/WHO PQ Approved Female Hormonal levonorgestrel Intrauterine Long-acting Marketed Bayer HealthCare 05/30/2018
LDH-C LDH-C4, Lactate dehydrogenase C Active Development Male Non-hormonal Oral Long-acting Target ID/Validation Northwestern University 05/30/2018
LevoCept Active Development Female Hormonal levonorgestrel Intrauterine Long-acting Phase II ContraMed, LLC 05/30/2018
Levogel Pericoital LNG gel Inactive Female Hormonal levonorgestrel Vaginal Gel Pericoital Phase I Population Council 05/30/2018
Liberté TT380 Short Smaller/Nulliparous Copper IUD SRA/WHO PQ Approved Female Non-hormonal copper Intrauterine Long-acting Marketed 7Med Industrie, France 05/30/2018
LIF and IL - 11 Leukemia inhibitory factor (LIF) and interleukin-11 (IL-11) Inactive Female Non-hormonal Short-acting Target ID/Validation Prince Henry's Institute of Medical Research, Australia 05/30/2018
Liletta LNG IUS Levosert (U.K.), Erlacela (Portugal), Donasert (Romania) SRA/WHO PQ Approved Female Hormonal levonorgestrel Intrauterine Long-acting Marketed Actavis, Medicines360 05/30/2018
LNG + EE Patch Twirla, AG200-15, Levonorgestrel + ethinyl estradiol patch Active Development Female Hormonal levonorgestrel, ethinyl estradiol Transdermal Short-acting Phase III Agile Therapeutics 05/30/2018
LNG butanoate Active Development Female, Male Hormonal levonorgestrel butanoate Injectable Long-acting Phase I WHO HRP, CONRAD, NICHD 05/30/2018
LNG ICD Levonorgestrel (LNG) Intracervical Device (ICD) Inactive Female Hormonal levonorgestrel Vaginal, Other Long-acting Phase I University of Helsinki, Population Council 05/30/2018
LNG patch Levonorgestrel (LNG)-only patch; AG890 Active Development Female Hormonal levonorgestrel Transdermal Short-acting Phase I Agile Therapeutics 05/30/2018
LNG-1 Implant One-year LNG Single Rod Implant Inactive Female Hormonal levonorgestrel Subdermal Long-acting Phase I CONRAD, FEI Technologies 05/30/2018
LNG-encapsulated Injectable PLGA Microspheres Active Development Female Hormonal levonorgestrel Injectable Long-acting Pre-clinical Stanford University 07/21/2016
Long-acting Etonogestrel Microspheres Active Development Female Hormonal etonogestrel Injectable, Subdermal Long-acting Pre-clinical Orbis Biosciences 05/30/2018
Lower-Dose DMPA Active Development Female Hormonal medroxyprogesterone acetate Injectable Long-acting Phase I FHI 360 05/30/2018
Export to Excel